Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
COSM 
Cosmos Health Inc. (COSM)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/17/2025: COSM (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $3
1 Year Target Price $3
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 4.39% | Avg. Invested days 33 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 32.10M USD | Price to earnings Ratio - | 1Y Target Price 3 |
Price to earnings Ratio - | 1Y Target Price 3 | ||
Volume (30-day avg) 1 | Beta 4.24 | 52 Weeks Range 0.28 - 1.32 | Updated Date 10/17/2025 |
52 Weeks Range 0.28 - 1.32 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -27.9% | Operating Margin (TTM) -17.94% |
Management Effectiveness
Return on Assets (TTM) -14.67% | Return on Equity (TTM) -52.69% |
Valuation
Trailing PE - | Forward PE 52.63 | Enterprise Value 49386627 | Price to Sales(TTM) 0.58 |
Enterprise Value 49386627 | Price to Sales(TTM) 0.58 | ||
Enterprise Value to Revenue 0.9 | Enterprise Value to EBITDA -1.6 | Shares Outstanding 31013876 | Shares Floating 20355088 |
Shares Outstanding 31013876 | Shares Floating 20355088 | ||
Percent Insiders 28.16 | Percent Institutions 8.57 |
Upturn AI SWOT
Cosmos Health Inc.
Company Overview
History and Background
Cosmos Health Inc., formerly known as Farmakos S.A., is a global healthcare company that was incorporated in Greece. It focuses on developing, manufacturing, and distributing branded and generic pharmaceuticals, over-the-counter (OTC) medications, and medical devices.
Core Business Areas
- Pharmaceuticals: Develops, manufactures, and distributes generic and branded pharmaceutical products.
- OTC Medications: Offers a range of over-the-counter medications for various health needs.
- Medical Devices: Manufactures and distributes medical devices and healthcare products.
Leadership and Structure
Information regarding Cosmos Health Inc.'s leadership team and organizational structure can be found on their investor relations page.
Top Products and Market Share
Key Offerings
- Generic Pharmaceuticals: Generic drugs including cardiovascular, pain management, anti-infectives. Market share data is limited for Cosmos Health individually. Competitors include Teva, Mylan, and Sandoz.
- OTC Products: Range of OTC drugs including cough and cold, pain relief, and first aid. Market share is limited. Competitors include Johnson & Johnson, Bayer, and GSK.
- Medical Devices: Cosmos Health offers a range of medical supplies. Specific data regarding Cosmos Health Inc.s revenue and market share are not readily available, and the competitive landscape for this is highly varied
Market Dynamics
Industry Overview
The healthcare industry is experiencing growth due to an aging population and increasing demand for medical products. The OTC drug market is also expanding driven by consumers looking to self-treat minor ailments. The medical device market is constantly innovating.
Positioning
Cosmos Health Inc. is positioned as a global healthcare company with a focus on generic pharmaceuticals, OTC medications, and medical devices. Competitive advantages might be its global reach and diverse product portfolio.
Total Addressable Market (TAM)
TAM for global generic pharmaceuticals, OTC medications, and medical devices is in the trillions of USD. Cosmos Health is positioned to serve niche markets.
Upturn SWOT Analysis
Strengths
- Global presence
- Diverse product portfolio
- Manufacturing capabilities
- Experience in Pharmaceutical industry
Weaknesses
- Limited brand recognition
- Smaller scale compared to major players
- Financial performance
- Market Share is less compared to other players
Opportunities
- Expanding into new markets
- Acquiring smaller companies
- Developing innovative products
- Increase Market Share
Threats
- Increased competition
- Regulatory changes
- Economic downturns
- Intellectual property risks
Competitors and Market Share
Key Competitors
- Teva Pharmaceutical Industries Ltd. (TEVA)
- Viatris Inc. (VTRS)
- Sun Pharmaceutical Industries Ltd. (SUNPHARMA.NS)
Competitive Landscape
Cosmos Health faces intense competition from larger, more established pharmaceutical and healthcare companies. The company needs to focus on niche markets and strategic acquisitions to improve its competitive position.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends need to be sourced directly from the investors section on their website
Future Projections: Future projections are based on analysts' estimates. These should be sourced from reputable financial news sources and analysts.
Recent Initiatives: Recent strategic initiatives would be highlighted on their Investor Relations page or in press releases.
Summary
Cosmos Health is a global healthcare company facing strong competition and financial constraints. While the company operates in a growing market, its smaller scale and limited brand recognition pose challenges. Strategic acquisitions and innovative product development are essential for future growth, while strong balance sheet and positive cashflow is a must. Investors should monitor its financial performance and strategic initiatives closely.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Company Investor Relations
- Financial News Sources
- Analyst Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Investment decisions should be based on thorough research and consultation with a financial professional.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cosmos Health Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2012-10-11 | Chairman & CEO Mr. Grigorios Siokas | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 149 | |
Full time employees 149 | |||
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvastatin), Miltus (Donepezil), Newzypra (Olanzapine), PNEUMO-KAST (Montelukast), Sahar (Pioglitazone), VIVALCID (Leucovorin), and Diabit-is (Sitagliptin). In addition, the company offers branded biocides and antiseptic soaps under the C-Sept and C-Scrub brand names; and other pharmaceutical products include Melatonin Spray, used to reduce insomnia and jet lag; Otikon ear drops, which is a Class II medical device in the form of ear drops; and baby foods, such as organic powder milk, pasta with minced meat, whole grain rice cereals, whole grain cereal porridges, and organic rice creams with vanilla milk, as well as pear, carrot and banana purée under the Bio-bebe brand. It serves wholesalers and retail healthcare providers. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.